EUVIMEDEUVIMED entdecken
Crossref

Nd:YAG laser vitreolysis in the treatment of premacular subhyaloid hemorrhage

Martina Milkovska, Ilian Shandurkov

Bulgarian Review of Ophthalmology · 2022

DOI: 10.14748/bro.v66i2.8603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulgarian Review of Ophthalmology, 2022. Verfasst von Martina Milkovska und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preretinal subhyaloid hemorrhage forms in bursa premacularis where, in an area of localized detachment of the vitreous from the retina, blood accumulates between the macula and the posterior hyaloid leading to a sudden painless loss of vision.

Aim

The aim of this article is to present an advanced method of laser treatment of subhyaloid hemorrhages located in bursa premacularis with neodymium:yttrium alluminum garnet (Nd:YAG) laser vitreolysis. Materials and Methods : Three eyes of three patients with subhyaloid hemorrhage and a history of a sudden visual loss were studied. We followed up the patients by optical coherence tomography, visual acuity examination, ophthalmoscopy, and digital fundus photography. In all patients there was no tendency for spontaneous resorption of the blood collected in bursa premacularis. We performed Nd:YAG laser vitreolysis at a declivity spot in the posterior hyaloid using power of 6 mJ.

Results

In two of the patients, a month after the laser treatment, there was complete visual recovery. The third patient had vitreous hemorrhage, diffuse preretinal hemorrhage with horizontal blood level and underlying choroidal neovascularization (CNV). We started conservative treatment of the vitreous hemorrhage followed by Nd:YAG laser vitreolysis, and three intravitreal pars plana anti-vascular endothelial growth factor (anti-VEGF) applications over three consecutive months. Visual acuity improved from counting fingers, PPLC, initially to 0.1 a week after the vitreolysis and 0.9 after the completion of the anti-VEGF treatment. In the absence of underlying aneurysm or choroidal rupture, we observed no recurrence of the hemorrhage or deterioration of the visual acuity in any of the patients during the follow-up period (1 to 5 years).

Discussion

Nd:YAG laser vitreolysis is a non-invasive procedure providing a way for the blood to drain into the vitreous cavity where it undergoes spontaneous resorption within a few weeks without complications. When used in combination with anti-VEGF in patients with neovascular form of age-related macular degeneration (AMD), it results in fast improvement in vision with minimal risk of complications.

Conclusion

Early application of Nd:YAG laser vitreolysis in recent subhyaloid hemorrhages is a quick, minimally invasive, and effective method of treatment. In combination with anti-VEGF, it is a method of choice for the treatment of subhyaloid hemorrhages in neovascular AMD.

Zitieren

APA

Milkovska, M., & Shandurkov, I. (2022). Nd:YAG laser vitreolysis in the treatment of premacular subhyaloid hemorrhage. Bulgarian Review of Ophthalmology. https://doi.org/10.14748/bro.v66i2.8603

Vancouver

Milkovska M, Shandurkov I. Nd:YAG laser vitreolysis in the treatment of premacular subhyaloid hemorrhage. Bulgarian Review of Ophthalmology. 2022. doi:10.14748/bro.v66i2.8603

BibTeX
@article{Milkovska2022,
  author = {Milkovska, Martina and Shandurkov, Ilian},
  title = {Nd:YAG laser vitreolysis in the treatment of premacular subhyaloid hemorrhage},
  journal = {Bulgarian Review of Ophthalmology},
  year = {2022},
  doi = {10.14748/bro.v66i2.8603}
}
Kostenlos starten →